Teva Pharma Industries Ltd ADR (TEVA)

Exchange: USA Stocks • Country: Israel • Currency: USD • Type: Common Stock • ISIN: US8816242098

Teva Pharmaceutical Industries Limited, traded as ADR on NYSE under the symbol TEVA, is a global company that develops, manufactures, and distributes generic medicines, specialty medicines, and biopharmaceutical products across North America, Europe, Israel, and internationally.

The company's product range includes a variety of generic medicines in different forms like tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, creams, sterile products, hormones, high-potency drugs, cytotoxic substances, and products that combine medical devices with medications.

Teva Pharma focuses on therapeutic areas such as the central nervous system (CNS), respiratory, and oncology. They supply active pharmaceutical ingredients, offer contract manufacturing services, and have an out-licensing platform that provides a product portfolio to other pharmaceutical companies.

Some of Teva's well-known drugs include BENDEKA, TREANDA, COPAXONE, AJOVY, AUSTEDO, GRANIX, and more. They also market over-the-counter products under leading names like SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA.

Established in 1901 and headquartered in Tel Aviv, Israel, Teva Pharma has collaboration agreements with companies like MedinCell, Sanofi, Alvotech, and Biolojic Design Ltd., along with a license agreement with MODAG GmbH.

For more information, you can visit their website at https://www.tevapharm.com.

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Teva Pharma Industries Ltd ADR (TEVA)

TEVA Stock Overview

Market Cap in USD 14,440m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1990-03-26

TEVA Stock Ratings

Fundamental -1.37
Dividend 3.76
Growth 5y -0.46
Rel. Performance vs Sector 1.38
Analysts 3.92
Fair Price Total Ret. 12.66
Fair Price DCF 20.56

TEVA Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 75.1%

TEVA Growth Ratios

Growth 12m 34.21%
Growth Correlation 12m 49%
Growth Correlation 3m 84%
CAGR 5y -4.87%
CAGR / Mean Drawdown -0.11
Sharpe Ratio 12m 0.79
Alpha vs SP500 12m -1.79
Beta vs SP500 5y weekly 1.25
CAPM 8.70%
Average Daily Range 2m 2.87%
Regime Oscillator 81.29
Volatility GJR Garch 1y 35.60%
Price / SMA 50 13.87%
Price / SMA 200 39.27%
Current Volume 7961.9k
Average Volume 20d 13026.9k

External Links for TEVA Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of TEVA stocks?
As of February 28, 2024, the stock is trading at USD 13.30 with a total of 7,961,868 shares traded.
Over the past week, the price has changed by +1.76%, over one month by +11.67%, over three months by +34.62% and over the past year by +34.34%.
Why is TEVA stock down?
Check with which Index or Commodity TEVA has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return TEVA Return S&P 500
1 Month 11.67% 4.00%
3 Months 34.62% 11.99%
12 Months 34.34% 29.39%
What is the forecast for TEVA stock price target?
According to ValueRays Forecast Model, TEVA Teva Pharma Industries Ltd ADR will be worth about 13.7 in February 2025. The stock is currently trading at 13.30. This means that the stock has a potential upside of +2.78%.
Issuer Forecast Upside
Wallstreet Target Price 14.6 10.0%
Analysts Target Price 10.6 -20.6%
ValueRay Target Price 13.7 2.8%